Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 22.98
    Last
  • 0.36  -1.54%
    Today's Change
  • 23.34
    Previous Close
  • Today
     
    16.85
    28.48
    52 Week Low - High
3:04 pm ET 7/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding37 million
Market Cap$860 million
Return on Equity ttm4.15%
Last DividendEBS:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.702
EPS: Year Est. 12/14 ttm1.050
 
EPS: Quarterly Actual 3/14 -0.40
EPS: Quarterly Est. 6/14 0.30
 
Price/Earnings ttm32.71
Relative Price/Earnings1.792
Earnings Growth Rate32.31
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$313 million
Net Income$31 million
Total Assets$627 million
Employees1,353
Web Sitewww.emergentbiosolutions.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!